Daily News header

Company Reply to Rare Earth Story

By  

Lynas Corporation has taken exception to an implication in my recent story on Green Jobs

The only part of the article they objected to was:

"China's government owned mining companies immediately offered to buy 51% of Lynas and 25% of Arafura."

This was completely accurate and the point of the story was that China is attempting to control any portion of the rare earth element market which it does not already own.

What Lynas would like everyone to know is that that purchase offer was blocked and they now have funding through other sources (see their complete email below.)

I have requested details about the funding and projections of when they expect to be in production.

Lynas' Reply:

"High-Paying Green Jobs in U.S. - Another Fantasy?

Dear John

I note in the above article you reference Lynas lost funding due to the GFC - which is correct, and that a Chinese group completed due diligence and offered to fund development of our Rare Earths project - which is also correct. However you failed to mention that the Australian Foreign Investment Review Board blocked this deal, and that JP Morgan assisted Lynas in raising all required funds to complete this project. I realise these facts don't support your story, but I would like to think you would give the full and balanced picture to your readers.

Lynas would request you print a correction as your current story gives the impression Lynas remains either without necessary funding or under Chinese ownership - both of which are incorrect.

Regards

Matthew James
Dr. Matthew James
Vice President
Corporate and Business Development
Lynas CORPORATION LTD
Office: +61 2 8259 7177
Mobile: +61 410 711 324
Fax: +61 2 8259 7199

John McCormick is a reporter, /science/medical columnist and finance and social commentator, with 17,000+ bylined stories. Contact John through NewsBlaze.

  Please leave a comment here     If it does not display within 10 seconds, please refresh the page

* The views of Opinion writers do not necessarily reflect the views of NewsBlaze

Related Australia News

The Global Alliance for TB Drug Development (TB Alliance) announced on February 19, 2015 the start of the first human study of a new TB drug candidate TBA-354-the first new potential TB drug to begin a Phase 1 clinical study in 6 years since 2009.
Sometimes there is a waste in health and medical research, says Dr Hans Lund, Chair of EBRNetwork Steering Group and a senior researcher at University of Southern Denmark.
Before World Cancer Day, an acquaintance succumbed to this disease within 10 months of diagnosis, and became part of the world statistics of someone dying of lung cancer every 30 seconds.
Every 30 seconds, someone in the world dies of lung cancer. According to the World Cancer Report 2014, more people die from lung cancer than from any other type.
Smoking has had a great adverse impact on many communities and has been directly responsible for the plight of those who are slowly wasting away from the ravages of lung cancer.
(CNS): It is not only about preventing new births of thalassemic infants; about chelation, about blood transfusion and about availability of services needed; but also about preventing complications related to Thalassaemia.

 

NewsBlaze Writers Of The Month


Popular Stories This Month

newsletter logo

landing page ad

NewsBlaze
Copyright © 2004-2014 NewsBlaze Pty. Ltd.
Use of this website is subject to our Terms of Service and Privacy Policy  | DMCA Notice               Press Room   |    Visit NewsBlaze Mobile Site